Abstract: Ectoparasites, such as fleas, ticks, mites and lice, are removed from a human or animal host after applying a composition that causes the temperature of the treated area to become higher or lower than normal. In one embodiment, treatment is effected by applying a composition that releases heat when contacted with water. The elevated or decreased temperature immobilizes the parasites and facilitates their mechanical removal, such as by combing.

Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.

Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.

Abstract: A counter for counting delivered doses from a spray dispenser of a type having a main body holding a fluid substance to be dispensed and a cap with a pump and nozzle mounted on the main body, the counter including: a counter body having an upper recess for receiving the main body; a button in an arcuate lower depression on the counter body for actuation by a person's thumb when a dose is dispensed; a display on the counter body for displaying a number of doses dispensed from the main body; a circuit which changes the number of doses display each time that the button is depressed; a set button for setting a starting number which is displayed on the display, corresponding to a predetermined number of doses remaining in the spray dispenser; and a sound generator which generates an audible sound upon each depression of the button.

Abstract: A skin barrier lotion for protection against contact with irritants comprises: about 5 to 15 percent by weight of a long-chain fatty acid; about 1 to 5 percent by weight of a long-chain fatty alcohol; about 1 to 10 percent by weight of a hydrocarbon oil; about 1 to 30 percent by weight of a silicone skin protectant; about 0.5 to about 5 percent by weight of an alkanolamine; about 0.5 to about 5 percent by weight of a humectant; about 0.5 to about 10 percent by weight of an inorganic skin protectant; about 0.5 to 15 weight percent of a preservative; and about 50 to 90 percent by weight water. Optionally, the lotion will also contain up to about 5 percent by weight of a fragrance, odor neutralizer or a mixture thereof.

Abstract: Methods of preparing particulates for agglomeration, having a specified particle size distribution and desired convertible amorphous content, are described. The method involves a plurality of micronizing steps at least two of which are separated by a curing step. In the curing step, a stimulus such as humidity may be used to crystallize at least some, and in many instances preferably all, of the convertible amorphous content.

Abstract: The invention relates to storage stable insect repellent emulsion formulations containing N,N-Diethyl-m-toluamide, together with water, a film-forming polymer and an emulsifier-emulsion stabilizer.

Abstract: An optical transmitter includes a light source emitting input light; and a modulator modulating the input light in accordance with an input electric signal to generate an optical transmission signal. The transmitter also includes a monitor which detects frequency fluctuation of the optical transmission signal. The modulator is controlled so as to optimize the amount of frequency fluctuation of the optical transmission signal.

Abstract: An aqueous-based sprayable composition comprises a therapeutic or palliative agent, water and a mixture of microcrystalline cellulose and alkali metal carboxyalkylcellulose. In one embodiment, the composition is a non-Newtonian nasal spray exhibiting a very rapid viscosity recovery upon removal of shear forces.

Abstract: A synchronization acquiring method capable of reducing the length of time required to perform in wireless communication a synchronization acquiring operation is provided when the mobile station transits from a sleep state to an active state. A synchronization acquiring apparatus capable of performing such a synchronization acquiring method is also provided. The method has the following three steps. In the first step, multiple correlation values are obtained between the input data supplied from a base station to the mobile station and multiple phases of a spreading code multiplied to the input data in the mobile station before the mobile station transits from the active state to the sleep state, multiple phases of the spreading code that correspond to the correlation values are determined, and the multiple phases are stored. In the second step, phases of the spreading code multiplied to the input data are determined using the phase when the mobile station transits from the sleep state to the active state.

Abstract: An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid.

Abstract: The invention relates to a method of producing an agglomerate of drug and solid binder. The process involves producing individual agglomerate particles and then converting the convertible amorphous content of same, following agglomeration, by the application of, for example, moisture. Agglomerates capable of conversion as well as the finished agglomerates and oral and nasal dosing systems including same are also contemplated. The process produces agglomerates which are rugged but which will produce an acceptable fine particle fraction during dosing.

Abstract: Aerosol formulations substantially free of chlorofluorocarbons, for oral and/or nasal administration, are described. The formulations comprise 1,1,1,2-tetrafluoroethane, a medicament, optionally an excipient and optionally a surfactant. Methods of treatment using the formulations also are described.

Abstract: The invention relates to a method of producing an agglomerate of drug and solid binder. The process involves producing individual agglomerate particles and then converting the convertible amorphous content of same, following agglomeration, by the application of, for example, moisture. Agglomerates capable of conversion as well as the finished agglomerates and oral and nasal dosing systems including same are also contemplated. The process produces agglomerates which are rugged but which will produce an acceptable fine particle fraction during dosing.

Abstract: K×K optical switch unit according to the present invention is comprised of input ports 1-1, . . . 1-36, 1×M optical matrix switches 5-1-1, . . . 5-4-9 connected with the input ports 1-1, . . . 1-36, N×N optical matrix switches 7-1-1, . . . 7-4-2, and 10-1-1, . . . 10-4-2 connected with the 1×M optical matrix switches 5-1-1, . . . 5-4-9, an M×1 optical matrix switches 13-1-1, . . . 13-4-9 connected with the N×N optical matrix switches 7-1-1, . . . 7-4-2, and 10-1-1, . . . 10-4-2, and output ports 2-1, . . . 2-36 connected with the M×1 optical matrix switches 13-1-1, . . . 13-4-9, where K=M×N, M and N are integers more than 1.